Meadow Creek Investment Management’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$13.9M Sell
231,220
-116,974
-34% -$7.39M 0.27% 77
2019
Q2
$22.1M Sell
348,194
-122,320
-26% -$8.03M 0.44% 55
2019
Q1
$34.1M Sell
470,514
-50,930
-10% -$3.56M 0.69% 28
2018
Q4
$33.1M Buy
521,444
+31,416
+6% +$2.19M 0.77% 27
2018
Q3
$37.8M Buy
490,028
+24,552
+5% +$1.92M 0.74% 26
2018
Q2
$36.8M Buy
465,476
+45,958
+11% +$3.61M 0.78% 25
2018
Q1
$33.8M Buy
419,518
+50,842
+14% +$4.02M 0.73% 26
2017
Q4
$26.2M Sell
368,676
-23,958
-6% -$1.75M 0.57% 35
2017
Q3
$28.5M Sell
392,634
-24,112
-6% -$1.69M 0.66% 32
2017
Q2
$27.7M Sell
416,746
-15,994
-4% -$1.02M 0.66% 33
2017
Q1
$25.8M Sell
432,740
-13,882
-3% -$798K 0.62% 35
2016
Q4
$25M Buy
+446,622
New +$23.9M 0.65% 35

Other funds holding CTSH

Meadow Creek Investment Management's CTSH Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Cognizant (CTSH) stake by 34% in Q3 2019, selling an estimated $7.39M and leaving 231,220 shares worth $13.9M. The position accounts for 0.27% of the portfolio, ranked #77.

Meadow Creek Investment Management first reported a position in CTSH in Q4 2016 and has held it in 12 quarters since. The position peaked at $37.8M in Q3 2018. 898 funds tracked by Wall St. Rank hold CTSH as of Q3 2019.

  • Meadow Creek Investment Management held 231,220 shares of Cognizant worth $13.9M as of Q3 2019.
  • Meadow Creek Investment Management sold 116,974 Cognizant shares in Q3 2019, an estimated $7.39M.
  • Cognizant made up 0.27% of Meadow Creek Investment Management's portfolio in Q3 2019, its #77 holding.
  • Meadow Creek Investment Management first reported a position in Cognizant in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Cognizant position peaked at $37.8M in Q3 2018.
  • 898 funds tracked by Wall St. Rank held Cognizant as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.